Literature DB >> 6263874

Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking.

M Kasuga, E Van Obberghen, S P Nissley, M M Rechler.   

Abstract

The structure of receptors for insulin-like growth factors in rat liver plasma membranes and the BRL 3A2 rat liver cell line has been examined by chemical cross-linking with disuccinimidyl suberate and sodium dodecyl sulfate-polyacrylamide gel electrophoresis under reducing and nonreducing conditions. Two receptor subtypes have been identified: (i) 125I multiplication-stimulating activity cross-linked to liver membranes or intact cells appeared in a complex of Mr = 260,000 (reduced) and 220,000 (nonreduced) and (ii) 125I-insulin-like growth factor I cross-linked to BRL 3A2 cells appeared predominantly in two bands of Mr greater than 300,000 without disulfide reduction and in a Mr = 130,000 complex following reduction. The two subtypes of insulin-like growth factor receptors identified by structural analysis correspond to previously observed differences in their specificity for insulin and insulin-like growth factors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6263874

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex.

Authors:  M Tsudo; R W Kozak; C K Goldman; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 2.  Somatomedins: chemical and functional characteristics of the different molecular forms.

Authors:  A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

3.  [Regulation of acinar cell receptors of the pancreas by peptides].

Authors:  J Mössner; W Fischbach
Journal:  Klin Wochenschr       Date:  1986-06-02

4.  Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulinlike growth factor I.

Authors:  D R Clemmons; R G Elgin; V K Han; S J Casella; A J D'Ercole; J J Van Wyk
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

5.  Specific binding of insulin-like growth factors 1 and 2 to the type 1 and type 2 receptors respectively.

Authors:  F J Ballard; M Ross; F M Upton; G L Francis
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

6.  Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro.

Authors:  V F Tapson; M Boni-Schnetzler; P F Pilch; D M Center; J S Berman
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

7.  Does IGF-1 play a role in the etiopathogenesis of non-functioning adrenocortical adenoma?

Authors:  C T Bahadir; G C Ecemis; H Atmaca
Journal:  J Endocrinol Invest       Date:  2018-03-14       Impact factor: 4.256

8.  Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.

Authors:  X Wu; Z Fan; H Masui; N Rosen; J Mendelsohn
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization.

Authors:  P B Bitterman; S I Rennard; G W Hunninghake; R G Crystal
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

10.  Characterization of the human receptor for T-cell growth factor.

Authors:  W J Leonard; J M Depper; R J Robb; T A Waldmann; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.